Cholestatic liver injury appears to result from the induction of hepatocyte
apoptosis by toxic bile salts such as glycochenodeoxycholate (GCDC). Previ
ous studies from this laboratory indicate that cathepsin B is a downstream
effector protease during the hepatocyte apoptotic process. Because caspases
can initiate apoptosis, the present studies were undertaken to determine t
he role of caspases in cathepsin B activation. Immunoblotting of GCDC-treat
ed McNtcp.24 hepatoma cells demonstrated cleavage of poly(ADP-ribose) polym
erase and Iamin B-1 to fragments that indicate activation of effector caspa
ses. Transfection with CrmA, an inhibitor of caspase 8, prevented GCDC-indu
ced cathepsin B activation and apoptosis. Consistent with these results, an
increase in caspase 8-like activity was observed in GCDC-treated cells. Ex
amination of the mechanism of GCDC-induced caspase 8 activation revealed th
at dominant-negative FADD inhibited apoptosis and that hepatocytes isolated
from Fas-deficient lymphoproliferative mice were resistant to GCDC-induced
apoptosis. After GCDC treatment, immunoprecipitation experiments demonstra
ted Fas oligomerization, and confocal microscopy demonstrated Delta FADD-GF
P (Fas-associated death domain-green fluorescent protein, aggregation in th
e absence of detectable Fas Ligand mRNA. Collectively, these data suggest t
hat GCDC-induced hepatocyte apoptosis involves ligand-independent oligomeri
zation of Fas, recruitment of FADD, activation of caspase 8, and subsequent
activation of effector proteases, including downstream caspases and cathep
sin B.